These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7513247)

  • 1. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases.
    Shirai Y; Kawata S; Tamura S; Ito N; Tsushima H; Takaishi K; Kiso S; Matsuzawa Y
    Cancer; 1994 May; 73(9):2275-9. PubMed ID: 7513247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum transforming growth factor alpha level as a marker of hepatocellular carcinoma complicating cirrhosis.
    Tomiya T; Fujiwara K
    Cancer; 1996 Mar; 77(6):1056-60. PubMed ID: 8635123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bcl-2 and TGF-beta1 levels in patients with chronic hepatitis C, liver cirrhosis and hepatocellular carcinoma.
    Ali MA; Koura BA; el-Mashad N; Zaghloul MH
    Egypt J Immunol; 2004; 11(1):83-90. PubMed ID: 15724390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
    Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
    Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of plasma transforming growth factor-beta in patients with hepatocellular carcinoma.
    Shirai Y; Kawata S; Ito N; Tamura S; Takaishi K; Kiso S; Tsushima H; Matsuzawa Y
    Jpn J Cancer Res; 1992 Jul; 83(7):676-9. PubMed ID: 1325427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
    Sacco R; Leuci D; Tortorella C; Fiore G; Marinosci F; Schiraldi O; Antonaci S
    Cytokine; 2000 Jun; 12(6):811-4. PubMed ID: 10843770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma.
    Song BC; Chung YH; Kim JA; Choi WB; Suh DD; Pyo SI; Shin JW; Lee HC; Lee YS; Suh DJ
    Cancer; 2002 Jan; 94(1):175-80. PubMed ID: 11815974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating transforming growth factor-β and epidermal growth factor receptor as related to virus infection in liver carcinogenesis.
    Divella R; Daniele A; Gadaleta C; Tufaro A; Venneri MT; Paradiso A; Quaranta M
    Anticancer Res; 2012 Jan; 32(1):141-5. PubMed ID: 22213299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum des-gamma-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas.
    Saitoh S; Ikeda K; Koida I; Tsubota A; Arase Y; Chayama K; Kumada H
    Cancer; 1994 Dec; 74(11):2918-23. PubMed ID: 7525036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum level of thioredoxin in patients with hepatocellular carcinoma.
    Miyazaki K; Noda N; Okada S; Hagiwara Y; Miyata M; Sakurabayashi I; Yamaguchi N; Sugimura T; Terada M; Wakasugi H
    Biotherapy; 1998; 11(4):277-88. PubMed ID: 9950104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
    Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
    Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma.
    Harada K; Shiota G; Kawasaki H
    Liver; 1999 Aug; 19(4):318-25. PubMed ID: 10459631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of transforming growth factor-beta 1 in the urine of patients with hepatocellular carcinoma.
    Tsai JF; Chuang LY; Jeng JE; Yang ML; Chang WY; Hsieh MY; Lin ZY; Tsai JH
    Medicine (Baltimore); 1997 May; 76(3):213-26. PubMed ID: 9193456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.
    Tsai JF; Jeng JE; Chuang LY; Yang ML; Ho MS; Chang WY; Hsieh MY; Lin ZY; Tsai JH
    Br J Cancer; 1997; 75(10):1460-6. PubMed ID: 9166938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
    Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
    J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
    Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M
    Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined assessment of TGF-beta-1 and alpha-fetoprotein values improves specificity in the diagnosis of hepatocellular carcinoma and other chronic liver diseases in Malaysia.
    Yasmin Anum MY; Looi ML; Nor Aini AH; Merican I; Wahidah A; Mohd Radzi AH; Nor Azizah A; Othman NH
    Med J Malaysia; 2009 Sep; 64(3):223-7. PubMed ID: 20527273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating intercellular adhesion molecule-1 in chronic liver disease and hepatocellular carcinoma.
    Huang YS; Wu JC; Chan CY; Chao Y; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Aug; 62(8):487-95. PubMed ID: 10462824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of transforming growth factor beta-1 in chronic hepatitis and hepatocellular carcinoma associated with hepatitis C virus infection.
    Kim HG; Chung YH; Song BC; Kim J; Yang SH; Lee YS; Suh DJ
    Korean J Intern Med; 2000 Dec; 15(3):165-70. PubMed ID: 11242803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.